【HanKang Biotech】2026 Q1 EPS reported at -2.10 TWD
NQ Score
46/100
N1 Content Completeness
10
AI Summary (NQ-processed)
HanKang Biotech (7827), a Cayman Islands-based company, announced its financial results for the first quarter of 2026, reporting an EPS of -2.10 TWD, revenue of 0.00 billion TWD, and a net loss of 330 million TWD.
AI Analysis
Frequently Asked Questions
- Q: How is the performance of HanKang Biotech?
- A: The company reported a loss in Q1 2026 with an EPS of -2.10 TWD.